Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated, using rats, the effect of partial hepatectomy (PH) on hepatocellular carcinoma (
HCC
, KDH-8 and AH-66) cells, and the effect of
HCC
cells on the regeneration of remaining hepatocytes after PH. Our results showed that PH significantly enhanced the growth of
HCC
cells in rats. Tumor volume increased more significantly in the partially hepatectomized group (H-group) than in the control group, and the tumor wet weights on the 14th postoperative day were significantly higher in the H-group than in the control group. Such an enhanced growth effect of PH on the injected (s.c.)
HCC
cells was related to an abrupt increase of tumor volume within 24 hours after operation, which was supported by the mitotic indices (MI) of the KDH-8 cells. These phenomena of the enhanced growth of the
HCC
cells following PH were not observed at all in rats injected with estrogen receptor (ER)-negative mammary carcinoma (
SST
-2) or nonepithelial fibrosarcoma (KMT-75) cells. The MIs of the remaining hepatocytes after PH increased abruptly at the 30th postoperative hour and reached a maximum at the 36th postoperative hour, and the MIs were significantly higher in the H-group with the KDH-8 cells than in the H-group without them from the 42th to the 60th postoperative hour. In the control group, the MIs of hepatocytes were not regardless of the presence of KDH-8 cells. From these results, we speculate that some growth factor(s) induced by PH may act on injected (s.c.)
HCC
cells, and that the other growth factor(s) secreted by
HCC
cells may act on the regenerating hepatocytes after PH.
...
PMID:Kinetic changes of liver regeneration and hepatocellular carcinoma cells after partial hepatectomy in rats. 200 58
Targeting of G-protein coupled receptors (GPCRs) like somatostatin-14 (SST-14) could have a potential interest in delivery of anti-cancer agents to tumor cells. Attachment of
SST
to different nano-carriers e.g. polymeric nanoparticles is limited due to the difficulty of interaction between
SST
itself and those nano-carriers. Furthermore, the instability problems associated with the final formulation. Attaching of
SST
to gold nanoparticles (AuNPs) using the positive and negative charge of
SST
and citrate-AuNPs could be considered a new technique to get stable non-aggregated AuNPs coated with
SST
. Different analyses techniques have been performed to proof the principle of coating between AuNPs and
SST
. Furthermore, cellular uptake studies on
HCC
-1806, HELA and U-87 cell lines has been investigated to show the ability of AuNPs coated
SST
to enter the cells via
SST
receptors. Dynamic light scattering (DLS) indicated a successful coating of
SST
on the MUA-AuNPs surface. Furthermore, all the performed analysis including DLS, SDS-PAGE and UV-VIS absorption spectra indicated a successful coating of AuNPs with
SST
. Cellular uptake studies on
HCC
-1806, HELA and U-87 cell lines showed that the number of AuNPs-
SST
per cell is signiflcantly higher compared to citrate-AuNPs when quantified using inductively coupled plasma spectroscopy. Moreover, the binding of AuNPs-
SST
to cells can be suppressed by addition of antagonist, indicating that the binding of AuNPs-
SST
to cells is due to receptor-specific binding. In conclusion, AuNPs could be attached to
SST
via adsorption to get stable AuNPs coated
SST
. This new formulation has a potential to target
SST
receptors localized in many normal and tumor cells.
...
PMID:Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors. 2703 9